Andrew Makin Preclinical Consulting ApS

CVR 40625240 · Private limited company (ApS) · Active · Low risk

Andrew Makin Preclinical Consulting ApS is a Private limited company (ApS), founded on , based in Kokkedal. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 6 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 529k and a net result of DKK 198k. CEO: Andrew Makin.

Bankruptcy risk for Andrew Makin Preclinical Consulting ApS

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 18% of active Danish companies

Lowest riskHighest risk

Increases the risk

Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Return on assets15%+ · bankruptcy rate 5.1%0.58×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
40625240
Status
Active
Company type
Private limited company (ApS)
Founded
(7 years)
Address
Hvedevænget 35
2980 Kokkedal
Municipality
Fredensborg
Industry
Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Share capital
DKK 40k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 6
Missing annual reportNo
Negative equityNo
Equity ratio69.9%
Current ratio332%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 830kDKK 1.4m
Net profitDKK 198kDKK 492k
EquityDKK 529kDKK 781k
Total assetsDKK 757kDKK 1.1m
CashDKK 390k–
Short-term debtDKK 228k–
Tax owedDKK 56k–
Avg. employees2–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202591
1 Jan 2024 – 31 Dec 202449
1 Jan 2023 – 31 Dec 202385
1 Jan 2022 – 31 Dec 202261
1 Jan 2021 – 31 Dec 202128
1 Jul 2019 – 31 Dec 202070

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOAndrew MakinCurrent
Owner (100%)Andrew Makin Holdings ApSCurrent
FounderUlrik Fleischer-MichaelsenCurrent

The CEOs' other companies

Andrew Makin – 1 other companies

Address history (0 moves)

Hvedevænget 35, 2980 Kokkedal

Other companies at the same address

Similar companies in Fredensborg

Questions and answers about Andrew Makin Preclinical Consulting ApS

Has Andrew Makin Preclinical Consulting ApS gone bankrupt?

No, Andrew Makin Preclinical Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Andrew Makin Preclinical Consulting ApS?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of Andrew Makin Preclinical Consulting ApS?

Andrew Makin is the CEO of Andrew Makin Preclinical Consulting ApS.

When was Andrew Makin Preclinical Consulting ApS founded?

Andrew Makin Preclinical Consulting ApS was founded on 1 July 2019.

What is the equity of Andrew Makin Preclinical Consulting ApS?

Equity was DKK 529k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.